stoxline Quote Chart Rank Option Currency Glossary
  
Creative Medical Technology Holdings, Inc. (CELZ)
3.645  -0.125 (-3.32%)    07-19 13:08
Open: 3.6466
High: 3.6983
Volume: 965
  
Pre. Close: 3.77
Low: 3.645
Market Cap: 5(M)
Technical analysis
2024-07-19 1:18:55 PM
Short term     
Mid term     
Targets 6-month :  4.94 1-year :  5.77
Resists First :  4.23 Second :  4.94
Pivot price 3.65
Supports First :  3.4 Second :  2.9
MAs MA(5) :  3.66 MA(20) :  3.64
MA(100) :  4.54 MA(250) :  4.63
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  66.6 D(3) :  60.5
RSI RSI(14): 45.2
52-week High :  10.28 Low :  2.9
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CELZ ] has closed above bottom band by 46.8%. Bollinger Bands are 56.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.8 - 3.82 3.82 - 3.83
Low: 3.59 - 3.61 3.61 - 3.62
Close: 3.77 - 3.8 3.8 - 3.82
Company Description

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Headline News

Thu, 18 Jul 2024
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Update - Defense World

Fri, 12 Jul 2024
Here's Why Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) CEO Compensation Is The Least Of Shareholders Concerns - Yahoo Finance

Wed, 10 Jul 2024
Creative Medical Technology advances in cell therapy trials - Investing.com

Wed, 10 Jul 2024
Creative Medical Technology Holdings Provides Corporate Update - StockTitan

Wed, 27 Mar 2024
Creative Medical Technology Holdings Provides Corporate Update - Business Wire

Sun, 24 Mar 2024
Creative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 1 (M)
Held by Insiders 1.31e+006 (%)
Held by Institutions 2.7 (%)
Shares Short 18 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -5.53e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -62 %
Return on Assets (ttm) 557.8 %
Return on Equity (ttm) -28.4 %
Qtrly Rev. Growth 9000 %
Gross Profit (p.s.) 0
Sales Per Share -8.56
EBITDA (p.s.) 0
Qtrly Earnings Growth -3.8 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.43
Price to Cash Flow 2.74
Stock Dividends
Dividend 0
Forward Dividend 15930
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android